GG
Gofen & Glossberg’s Core Laboratories CLB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-27,170
| Closed | -$1.02M | – | 439 |
|
|
2019
Q4 | $1.02M | Buy |
27,170
+1,247
| +5% | +$47K | 0.03% | 214 |
|
|
2019
Q3 | $1.21M | Sell |
25,923
-3,047
| -11% | -$142K | 0.04% | 196 |
|
|
2019
Q2 | $1.52M | Sell |
28,970
-1,175
| -4% | -$61.4K | 0.05% | 181 |
|
|
2019
Q1 | $2.08M | Sell |
30,145
-1,289
| -4% | -$88.9K | 0.07% | 159 |
|
|
2018
Q4 | $1.88M | Sell |
31,434
-24,920
| -44% | -$1.49M | 0.07% | 162 |
|
|
2018
Q3 | $6.53M | Sell |
56,354
-1,734
| -3% | -$201K | 0.22% | 100 |
|
|
2018
Q2 | $7.33M | Buy |
58,088
+463
| +0.8% | +$58.4K | 0.27% | 93 |
|
|
2018
Q1 | $6.24M | Sell |
57,625
-1,825
| -3% | -$197K | 0.23% | 99 |
|
|
2017
Q4 | $6.51M | Buy |
59,450
+2,056
| +4% | +$225K | 0.23% | 100 |
|
|
2017
Q3 | $5.67M | Buy |
57,394
+5,192
| +10% | +$512K | 0.21% | 105 |
|
|
2017
Q2 | $5.29M | Buy |
52,202
+21,746
| +71% | +$2.2M | 0.2% | 103 |
|
|
2017
Q1 | $3.52M | Buy |
30,456
+12,223
| +67% | +$1.41M | 0.14% | 123 |
|
|
2016
Q4 | $2.19M | Buy |
18,233
+3,594
| +25% | +$431K | 0.09% | 155 |
|
|
2016
Q3 | $1.64M | Buy |
14,639
+177
| +1% | +$19.9K | 0.07% | 174 |
|
|
2016
Q2 | $1.79M | Buy |
14,462
+391
| +3% | +$48.4K | 0.08% | 170 |
|
|
2016
Q1 | $1.58M | Buy |
14,071
+2,852
| +25% | +$321K | 0.07% | 174 |
|
|
2015
Q4 | $1.22M | Buy |
11,219
+2,391
| +27% | +$260K | 0.05% | 186 |
|
|
2015
Q3 | $881K | Buy |
8,828
+7,010
| +386% | +$700K | 0.04% | 215 |
|
|
2015
Q2 | $207K | Buy |
+1,818
| New | +$207K | 0.01% | 425 |
|